Market Research Logo

Global Multiple Myeloma Market and Competitive Landscape – 2017

Global Multiple Myeloma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Multiple Myeloma Market and Competitive Landscape – 2017, provides comprehensive insights into Multiple Myeloma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Myeloma market size and drug sales. This research also provides insights into Multiple Myeloma epidemiology and late stage pipeline.
The report is classified into twelve sections – Multiple Myeloma overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Myeloma pipeline insights covering late stage clinical trials pipeline; Multiple Myeloma prevalence trends by countries; Multiple Myeloma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Multiple Myeloma pipeline: Find out the drugs in clinical trials for Multiple Myeloma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Multiple Myeloma epidemiology: Find out the prevalence of Multiple Myeloma by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Multiple Myeloma products: Identify key products marketed and prescribed for Multiple Myeloma by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Myeloma market size: Find out the market size for Multiple Myeloma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Multiple Myeloma drug sales: Find out the sales of Multiple Myeloma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Multiple Myeloma drugs sales forecast: Sales forecast for Multiple Myeloma drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Myeloma market share analysis: Find out the market shares of Multiple Myeloma drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Multiple Myeloma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Multiple Myeloma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Multiple Myeloma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Multiple Myeloma: Disease Overview
1.1. Multiple Myeloma Symptoms
1.2. Multiple Myeloma Etiology
1.3. Multiple Myeloma Diagnosis
1.4. Multiple Myeloma Treatment Options
2. Multiple Myeloma Pipeline Insights
2.1. Multiple Myeloma Phase 3 Clinical Trials
2.2. Multiple Myeloma Phase 2 Clinical Trials
2.3. Multiple Myeloma Phase 1 Clinical Trials
3. Multiple Myeloma Epidemiology Analysis
4. US Multiple Myeloma Market Insights
4.1. Marketed Products for Multiple Myeloma in US
4.2. US Multiple Myeloma Market Size & Forecast
4.3. US Multiple Myeloma Product Sales Forecast
4.4. US Multiple Myeloma Market Share Analysis
5. Germany Multiple Myeloma Market Insights
5.1. Marketed Products for Multiple Myeloma in Germany
5.2. Germany Multiple Myeloma Market Size & Forecast
5.3. Germany Multiple Myeloma Product Sales Forecast
5.4. Germany Multiple Myeloma Market Share Analysis
6. France Multiple Myeloma Market Insights
6.1. Marketed Products for Multiple Myeloma in France
6.2. France Multiple Myeloma Market Size & Forecast
6.3. France Multiple Myeloma Product Sales Forecast
6.4. France Multiple Myeloma Market Share Analysis
7. Italy Multiple Myeloma Market Insights
7.1. Marketed Products for Multiple Myeloma in Italy
7.2. Italy Multiple Myeloma Market Size & Forecast
7.3. Italy Multiple Myeloma Product Sales Forecast
7.4. Italy Multiple Myeloma Market Share Analysis
8. Spain Multiple Myeloma Market Insights
8.1. Marketed Products for Multiple Myeloma in Spain
8.2. Spain Multiple Myeloma Market Size & Forecast
8.3. Spain Multiple Myeloma Product Sales Forecast
8.4. Spain Multiple Myeloma Market Share Analysis
9. UK Multiple Myeloma Market Insights
9.1. Marketed Products for Multiple Myeloma in UK
9.2. UK Multiple Myeloma Market Size & Forecast
9.3. UK Multiple Myeloma Product Sales Forecast
9.4. UK Multiple Myeloma Market Share Analysis
10. Europe Multiple Myeloma Market Insights
10.1. Europe Multiple Myeloma Market Size & Forecast
10.2. Europe Multiple Myeloma Product Sales Forecast
10.3. Europe Multiple Myeloma Market Share Analysis
11. Japan Multiple Myeloma Market Insights
11.1. Marketed Products for Multiple Myeloma in Japan
11.2. Japan Multiple Myeloma Market Size & Forecast
11.3. Japan Multiple Myeloma Product Sales Forecast
11.4. Japan Multiple Myeloma Market Share Analysis
12. Global Multiple Myeloma Market Insights
12.1. Global Multiple Myeloma Market Size & Forecast
12.2. Global Multiple Myeloma Product Sales Forecast
12.3. Global Multiple Myeloma Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Multiple Myeloma Phase 3 Clinical Trials, Global, 2017
Table 2: Multiple Myeloma Phase 2 Clinical Trials, Global, 2017
Table 3: Multiple Myeloma Phase 1 Clinical Trials, Global, 2017
Table 4: Multiple Myeloma Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Multiple Myeloma in US, 2017
Table 6: US Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 8: US Multiple Myeloma Market Trends, 2012 - 2021
Table 9: Marketed Products for Multiple Myeloma in Germany, 2017
Table 10: Germany Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 12: Germany Multiple Myeloma Market Trends, 2012 - 2021
Table 13: Marketed Products for Multiple Myeloma in France, 2017
Table 14: France Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 16: France Multiple Myeloma Market Trends, 2012 - 2021
Table 17: Marketed Products for Multiple Myeloma in Italy, 2017
Table 18: Italy Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 20: Italy Multiple Myeloma Market Trends, 2012 - 2021
Table 21: Marketed Products for Multiple Myeloma in Spain, 2017
Table 22: Spain Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 24: Spain Multiple Myeloma Market Trends, 2012 - 2021
Table 25: Marketed Products for Multiple Myeloma in UK, 2017
Table 26: UK Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 28: UK Multiple Myeloma Market Trends, 2012 - 2021
Table 29: Europe Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Multiple Myeloma in Japan, 2017
Table 32: Japan Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 34: Japan Multiple Myeloma Market Trends, 2012 - 2021
Table 35: Global Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Multiple Myeloma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Multiple Myeloma Pipeline by Phase (%), Global, 2017
Figure 2: Multiple Myeloma Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 4: US Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 5: US Multiple Myeloma Market Share by Products (%), 2016
Figure 6: US Multiple Myeloma Market - Future Market Share (%), 2021
Figure 7: Germany Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 8: Germany Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 9: Germany Multiple Myeloma Market Share by Products (%), 2016
Figure 10: Germany Multiple Myeloma Market - Future Market Share (%), 2021
Figure 11: France Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 12: France Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 13: France Multiple Myeloma Market Share by Products (%), 2016
Figure 14: France Multiple Myeloma Market - Future Market Share (%), 2021
Figure 15: Italy Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 16: Italy Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 17: Italy Multiple Myeloma Market Share by Products (%), 2016
Figure 18: Italy Multiple Myeloma Market - Future Market Share (%), 2021
Figure 19: Spain Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 20: Spain Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 21: Spain Multiple Myeloma Market Share by Products (%), 2016
Figure 22: Spain Multiple Myeloma Market - Future Market Share (%), 2021
Figure 23: UK Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 24: UK Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 25: UK Multiple Myeloma Market Share by Products (%), 2016
Figure 26: UK Multiple Myeloma Market - Future Market Share (%), 2021
Figure 27: Europe Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 28: Europe Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 29: Europe Multiple Myeloma Market Share by Products (%), 2016
Figure 30: Europe Multiple Myeloma Market - Future Market Share (%), 2021
Figure 31: Japan Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 32: Japan Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 33: Japan Multiple Myeloma Market Share by Products (%), 2016
Figure 34: Japan Multiple Myeloma Market - Future Market Share (%), 2021
Figure 35: Global Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 36: Global Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 37: Global Multiple Myeloma Market Share by Products (%), 2016
Figure 38: Global Multiple Myeloma Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report